This year’s symposium will explore how the partnership between pharma and academia fuels breakthroughs that strengthen outbreak preparedness. Join colleagues from across the consortium, industry, public health, and academia for a lively exchange of ideas and insights. The event is sponsored by Harvard Medical School, the Maxwell Finland Fund, and the Warren Alpert Foundation.

Featured Speakers

  • Opening Remarks, 2025 Symposium Chair

    Bruce D. Walker
    The HMS Phillip T. and Susan M. Ragon Professor of Medicine, Massachusetts General Hospital
    Director, Ragon Institute

  • Moderator

    Gaurav Gaiha
    HMS Associate Professor of Medicine, Massachusetts General Hospital
    Principal Investigator, Ragon Institute

  • Keynote I

    Pirada Suphaphiphat Allen
    Pfizer
    “From Moonshot to Flu-shot”

  • Session I

    Lillian Juttukonda
    Boston Medical Center
    “Unique cell states induced by common respiratory viruses in young children”

    Yajuan Wang
    Boston Children’s Hospital
    “Structural Basis of Coronavirus Genomic RNA Packaging”

    Ninaad Lasrado
    Beth Israel Deaconess Medical Center
    “Development of a Clade 2.3.4.4b H5N1 Avian Influenza Vaccine for Mucosal Protection”

  • Keynote II

    Régis Gervier
    Sanofi
    “Innovating for better outbreak interception”

  • Session II

    Louise L. Hansen and Karan Malhotra
    Wyss Institute at Harvard
    “Ultrasensitive Multi-Analyte Detection Assays for Predicting Disease Trajectories”

    Adam Sychla
    Harvard Medical School
    “High-Dimensional Profiling and Prediction of Zoonotic Spillover Risk in Hundreds of Picornaviridae”

    Jarod Herrera
    Boston University Chobanian & Avedisian School of Medicine
    “Developing Tools to Study the Pathogenic Potential of Newly Emerging Henipaviruses”

  • Closing Remarks

    Nadine Fornelos Martins
    Executive Director of Research Initiatives, MassCPR